Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Heidi L. Weiss, PhD

Cancer Center Member

Associate Director, Shared Resource Facilities
Director, Biostatistics Shared Resource Facility

heidi weiss

Research Programs:
Drug Discovery, Delivery and Translational Therapeutics

Colleges & Departments:
College of Public Health, College of Medicine, Department of Biostatistics, Department of Surgery

Faculty Rank:

Research Focus

Design and analysis of early phase clinical trials focusing on Bayesian design and interim monitoring. Statistical analysis of transgenic, xenograft and chemically induced mouse models of cancer.

Contact Information

800 Rose Street
CC448 Roach Building, University of Kentucky
Lexington, KY 40536
United States



  1. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S and Elledge R. Breast Cancer Res Treat 129:819-27, 2011.
  2. Bayesian Monitoring of a phase II chemoprevention trial in high risk cohorts for prostate cancer. Weiss HL, Urban DA, Grizzle WE, Cronin KA, Freedman LS, Kelloff GJ, Lieberman R. Urology 57(4A):220-223, 2001.